2-piperidone has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HL; Duan, Y; Ling, M; Lv, XA; Ma, FX; Zhang, HC; Zhang, S | 1 |
| Aboussekhra, A; Al-Howail, HA; Al-Jammaz, I; Al-Khalaf, HH; Al-Mazrou, A; Al-Otaibi, B; Daghestani, MH; Hakami, HA | 1 |
2 other study(ies) available for 2-piperidone and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.
Topics: Animals; Benzylidene Compounds; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Mice; MicroRNAs; Piperidones; RNA, Long Noncoding; Sp1 Transcription Factor; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2022 |
PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells.
Topics: Animals; Antineoplastic Agents; Benzylidene Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokine CCL2; Curcumin; Drug Stability; Epithelial-Mesenchymal Transition; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Mice; Piperidones; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2016 |